Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Study: Edwards’ Sapien and Medtronic’s CoreValve outcomes are similar
A new study published in the Journal of the American College of Cardiology found that patients treated with Edwards Lifesciences’s and Medtronic’s CoreValve showed similar results after 1 year.
The 241-patient trial examined high-risk patients with symptomatic severe aortic stenosis 1 year after being treated with either Edwards’s Sapien balloon expanding or Medtronic’ self-expanding transcatheter heart valve. Read more
2. Google restructuring puts Life Sciences & Calico group under new umbrella
Google announced a corporate restructuring that places it under the new parent company Alphabet.
The company highlighted the separation of its med-device developer Life Sciences business and human-longevity focused Calico division. Read more
1. NxStage reveals next-gen hemo, peritoneal dialysis systems
NxStage Medical announced 3 new products in the pipeline for the dialysis-focused device company during a conference call discussing their quarterly earnings.
Included in the announcements was a next-generation portable hemodialysis system usable at home or in care centers, a new, simplified peritoneal dialysis machine and a critical care system. Read more